Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Study findings from University of Milan broaden understanding of adenocarcinoma
September 23rd, 2008
In this recent study, researchers in Monza, Italy conducted a study "To evaluate the status of activation of the intestinal dendritic cells (DCs) and T lymphocytes (T cells) from surgical specimens of human colon and adenocarcinoma, and the potential effect of administration of interleukin 2 (IL-2). Patients undergoing colectomy for cancer were randomized to receive subcutaneous IL-2 (12 million Ul/day) (treated group; n = 10) for 3 days before operation or no treatment (control group, n = 10)." "DCs and T cells were isolated and purified from the lamina propria (LP) of segments of normal colon and adenocarcinoma of both groups. Cell phenotype was determined by...
Source: Cancer Weekly (2008-09-23)
|
